Murray, Michael D.; Deardorff, Frank W. - In: PharmacoEconomics 14 (1998) 4, pp. 341-348
Managed-care organisations and the pharmaceutical industry have diametrically opposing objectives, though there is hidden common ground. On one hand, most managed-care organisations now want to reduce the cost of drugs or at least maintain drug costs as a hedge against inflation. On the other,...